Schizophrenia: open trials in United States

• NCT03094429

  An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults

  Trial Treatment · Phase 2/3 · SyneuRx International (Taiwan) Corp

  Pasadena

  Registry updated 2021-09-13

• NCT03495024

  Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates

  Trial Treatment · Phase 4 · Corporal Michael J. Crescenz VA Medical Center

  Corporal Michael J. Crescenz VA Medical Center, Philadelphia

  Registry updated 2019-03-22

All Schizophrenia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error